This episode of the "Immune" podcast explores two recent papers in mucosal immunology. The first discussion centers on a novel vaccination strategy published in Nature Biomedical Engineering that uses antigen-coated dental floss. This method targets the highly permeable gingival sulcus in the mouth to deliver vaccine components, aiming to induce both mucosal and systemic immunity. Studies in mice demonstrated that this technique can provide protection against influenza, primarily through a systemic IgG response. A human feasibility study confirmed that antigen delivery is possible, though inconsistent, highlighting user variability as a key challenge for this potentially more acceptable vaccination method.
The second half of the episode delves into a PNAS paper investigating the role of maternal secretory IgA (sIgA) from breast milk in shaping the infant's immune system. Building on the knowledge that sIgA controls the pro-inflammatory TH17-inducing Segmented Filamentous Bacteria (SFB) in mice, researchers sought the human equivalent. By analyzing a large Canadian infant cohort, they identified Aerisicipelotoclostridium ramosum as a key bacterium whose colonization is limited by targeted maternal sIgA. In vitro experiments revealed that this bacterium adheres to human intestinal cells and triggers a strong TH17 inflammatory response, a process that is blocked by sIgA. This human-specific interaction provides a direct mechanism explaining how breastfeeding helps regulate early-life inflammation and reduces the risk of allergic diseases.
Immune #96: Floss Vaccines and Milk Antibodies
0:05:24 The Quest for Mucosal Vaccines: The episode begins by discussing the goal of developing non-injectable vaccines to stimulate immunity directly at mucosal surfaces (e.g., respiratory or GI tracts), which are the primary sites of infection. A key challenge is overcoming the body's natural tendency toward "oral tolerance," where the immune system is trained not to react to substances encountered in the gut.
0:14:05 A Novel Delivery System: Floss-Based Vaccination: A new paper proposes a unique solution: delivering vaccine antigen coated onto dental floss. The target is the gingival sulcus, the space between the teeth and gums, which contains a highly permeable type of epithelium and abundant immune cells, making it an ideal site for antigen uptake.
0:20:53 Protection in a Mouse Model: In mouse experiments, flossing with floss coated in influenza antigen and an adjuvant (CPG) induced a protective immune response against subsequent infection. The protection was primarily driven by a systemic IgG antibody response, with little effect on mucosal IgA, suggesting this method is an effective way to achieve systemic immunization without an injection.
0:22:40 Human Feasibility and Challenges: A study in human volunteers using floss coated with food dye showed that participants could successfully deliver about 59% of the material to the target site. However, the high variability highlights that user error and inconsistent dosing would be a significant hurdle for real-world application.
0:27:39 The Role of Breast Milk in Infant Immunity: The second paper focuses on how secretory IgA (sIgA) in human breast milk shapes the infant gut microbiome and immune system. In mice, maternal sIgA controls a specific bacterium (SFB) that potently drives TH17 cell inflammation. Since humans lack SFB, this study aimed to find its functional equivalent.
0:39:51 Identifying a Keystone Inflammatory Bacterium: Using samples from the large Canadian CHILD cohort study, researchers identified Aerisicipelotoclostridium ramosum (E. ramosum) as a key microbe in the infant gut. The abundance of this bacterium was negatively correlated with the amount of maternal sIgA that specifically targeted it. Its presence has been linked to a higher risk of developing allergies.
0:46:39 Maternal IgA Prevents Gut Inflammation: In vitro experiments showed that live E. ramosum strongly adheres to human intestinal epithelial cells and triggers a powerful TH17-mediated inflammatory response. Crucially, sIgA from mothers' milk that binds to E. ramosum was shown to block this adherence, thereby preventing the inflammatory cascade.
0:50:46 A Human-Specific Finding: This interaction is highly species-specific. E. ramosum does not adhere to mouse intestinal cells and fails to induce an inflammatory response in mouse models. This underscores the importance of human cohort studies and the limitations of animal models for studying the gut microbiome.
1:01:52 Key Takeaway: Breastfeeding and Immune Health: The study provides a clear mechanism for how breastfeeding protects against allergic diseases. By providing targeted antibodies, breast milk controls the colonization of specific pro-inflammatory bacteria like E. ramosum, which helps calibrate the infant’s developing immune system and prevents excessive inflammation early in life.